Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue
admin 25th May 2017 Uncategorised 0Should drugs that win FDA approval on an accelerated path—often without strong evidence of efficacy—command the same high prices as products that undergo the full menu of agency scrutiny? Not necessarily, two doctors argue. And they have some ideas for bringing the costs of those drugs way down, at least until their makers can prove they really work.
More: Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue
Source: fierce